Veterinary Oncology Market Size, Share & Trends Report

Veterinary Oncology Market Size, Share & Trends Analysis Report By Therapy (Surgery, Radiology, Chemotherapy), By Animal Type (Canine, Feline), By Cancer Type, By Region, And Segment Forecasts, 2020 - 2027

  • Published Date: Apr, 2020
  • Base Year for Estimate: 2019
  • Report ID: GVR-4-68038-182-5
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2018
  • Number of Pages: 120

Table of Contents

Chapter 1 Research Methodology & Scope
                   1.1 Market Segmentation & Scope
                       1.1.1 Segment Scope
                       1.1.2 Regional Scope
                       1.1.3 Estimates & Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased database:
                       1.3.2 GVR’s Internal Database
                       1.3.3 Secondary sources
                       1.3.4 Primary Research:
                       1.3.5 Details of Primary Research
                   1.4 Information or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis (Model 1)
                   1.7 List of Secondary Sources
                   1.8 List of Primary Sources
                   1.9 Abbreviations
                   1.10 Objectives
                       1.10.1 Objective 1:
                       1.10.2 Objective 2:
                       1.10.3 Market Definitions
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Outlook
                   2.3 Competitive Outlook
Chapter 3 Veterinary Oncology Market Variables Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent market outlook
                       3.1.2 Ancillary market outlook
                   3.2 Penetration & Growth Prospect Mapping by Technology, 2019
                   3.3 User Perspective Analysis
                       3.3.1 Market influencer analysis
                   3.4 List of Key End Users
                   3.5 Regulatory Framework
                       3.5.1 Regulatory Landscape
                   3.6 Technology Overview
                       3.6.1 Veterinary Oncology timeline analysis
                   3.7 Market Dynamics
                       3.7.1 Market Driver Analysis
                           3.7.1.1 Upsurge in the prevalence of cancer in pet animals
                           3.7.1.2 Increasing research and investments in pet cancer
                           3.7.1.3 Growing focus on animal safety
                           3.7.1.4 Technological advancements in pet cancer treatment
                       3.7.2 Market Restraints Analysis
                           3.7.2.1 High cost of pet cancer treatment
                           3.7.2.2 Lack of awareness among pet owners about pet disease
                           3.7.2.3 Adverse effects of drugs used for pet cancer treatment
                   3.8 Industry Analysis - Porter’s
                       3.8.1 Supplier Power
                       3.8.2 Buyer Power
                       3.8.3 Threat of Substitutes
                       3.8.4 Threat of New Entrants
                       3.8.5 Competitive Rivalry
                   3.9 Veterinary Oncology - SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
                       3.9.1 Political Landscape
                       3.9.2 Economic Landscape
                       3.9.3 Technology Landscape
                       3.9.4 Social Landscape
                   3.10 Major Deals and Strategic alliances
Chapter 4 Veterinary Oncology Market: Competitive Analysis
                   4.1 Market Participation Categorization
                   4.2 Competitive Analysis
                       4.2.1 Company market position analysis
                       4.2.2 Market leader
                       4.2.3 Innovators
                       4.2.4 Vendor Landscape
                           4.2.4.1 List of veterinary Oncology service providers
Chapter 5 Veterinary Oncology Market: Therapy type analysis
                   5.1 Therapy Type Business Analysis
                       5.1.1 Surgery
                           5.1.1.1 Surgery market estimates and forecasts, 2016 - 2027 (USD Million)
                       5.1.2 Radiology
                           5.1.2.1 Radiology market estimates and forecasts, 2016 - 2027 (USD Million)
                       5.1.3 Chemotherapy
                           5.1.3.1 Chemotherapy market estimates and forecasts, 2016 - 2027 (USD Million)
                       5.1.4 Immunotherapy
                           5.1.4.1 Immunotherapy market estimates and forecasts, 2016 - 2027 (USD Million)
                       5.1.5 Others
                           5.1.5.1 Others market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 6 Veterinary Oncology Market: Animal Type
                   6.1 Animal Type Analysis
                       6.1.1 Canine
                           6.1.1.1 Canine market estimates and forecasts, 2016 - 2027 (USD Million)
                       6.1.2 Feline
                           6.1.2.1 Feline market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 7 Veterinary Oncology Market: Cancer Type
                   7.1 Cancer Type Business Analysis
                       7.1.1 Lymphoma
                           7.1.1.1 Lymphoma market estimates and forecasts, 2016 - 2027 (USD Million)
                       7.1.2 Mast Cell Cancer
                           7.1.2.1 Mast Cell Cancer market estimates and forecasts, 2016 - 2027 (USD Million)
                       7.1.3 Mammary and Squamous Cell Cancer
                           7.1.3.1 Mammary and Squamous Cell Cancer market estimates and forecasts, 2016 - 2027 (USD Million)
                       7.1.4 Others
                           7.1.4.1 Others market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 8 Veterinary Oncology: Regional Market Analysis, By Therapy, Animal type, and Cancer Type 2016 - 2027 (USD Million)
                   8.1 Regional Market Share Analysis, 2019 & 2027
                   8.2 Regional Market Dashboard
                   8.3 Regional Market Snapshot
                   8.4 Market Size, & Forecasts and Trend Analysis, 2019 to 2027
                       8.4.1 North America
                           8.4.1.1 Veterinary oncology market estimates and segment forecasts, 2016 - 2027 (USD Million)
                           8.4.1.2 U.S.
                               8.4.1.2.1 Veterinary oncology market estimates and forecasts, 2016 - 2027 (USD Million)
                           8.4.1.3 Canada
                               8.4.1.3.1 Veterinary oncology market estimates and forecasts, 2016 - 2027 (USD Million)
                       8.4.2 Europe
                           8.4.2.1 Veterinary oncology market estimates and forecasts by countries, 2016 - 2027 (USD Million)
                           8.4.2.2 U.K.
                               8.4.2.2.1 Veterinary oncology market estimates and forecasts, 2016 - 2027 (USD Million)
                           8.4.2.3 Germany
                               8.4.2.3.1 Veterinary oncology market estimates and forecasts, 2016 - 2027 (USD Million)
                       8.4.3 Asia Pacific
                           8.4.3.1 Veterinary oncology market estimates and forecasts, 2016 - 2027 (USD Million)
                       8.4.4 Latin America
                           8.4.4.1 Veterinary oncology market estimates and forecasts, 2016 - 2027 (USD Million)
                       8.4.5 MEA
                           8.4.5.1 Veterinary oncology market estimates and forecasts by countries, 2016 - 2027 (USD Million)
Chapter 9 Company Profiles
                   9.1 Boehringer Ingelheim International GmbH
                       9.1.1 Company Overview
                       9.1.2 Financial Performance
                       9.1.3 Product Benchmarking
                       9.1.4 Strategic Initiatives
                   9.2 Elanco
                       9.2.1 Company Overview
                       9.2.2 Financial Performance
                       9.2.3 Product Benchmarking
                       9.2.4 Strategic Initiatives
                   9.3 Zoetis
                       9.3.1 Company Overview
                       9.3.2 Financial Performance
                       9.3.3 Product Benchmarking
                       9.3.4 Strategic Initiatives
                   9.4 PetCure Oncology
                       9.4.1 Company Overview
                       9.4.2 Product Benchmarking
                       9.4.3 Strategic Initiatives
                   9.5 Accuray Incorporated
                       9.5.1 Company Overview
                       9.5.2 Financial Performance
                       9.5.3 Product Benchmarking
                       9.5.4 Strategic Initiatives
                   9.6 Varian Medical System, Inc.
                       9.6.1 Company Overview
                       9.6.2 Financial Performance
                       9.6.3 Product Benchmarking
                       9.6.4 Strategic Initiatives
                   9.7 Nippon Zenyaku Kogyo Co., Ltd.
                       9.7.1 Company Overview
                       9.7.2 Product Benchmarking
                       9.7.3 Strategic Initiatives
                   9.8 Morphogenesis, Inc.
                       9.8.1 Company Overview
                       9.8.2 Product Benchmarking
                       9.8.3 Strategic Initiatives
                   9.9 Karyopharm Therapeutics, Inc.,
                       9.9.1 Company Overview
                       9.9.2 Financial Performance
                       9.9.3 Product Benchmarking
                       9.9.4 Strategic Initiatives
                   9.10 Regeneus Ltd.
                       9.10.1 Company Overview
                       9.10.2 Financial Performance
                       9.10.3 Product Benchmarking
                       9.10.4 Strategic Initiatives
                   9.11 One Health
                       9.11.1 Company Overview
                       9.11.2 Product Benchmarking
                       9.11.3 Strategic Initiatives


List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 List of veterinary oncology service providers
TABLE 4 North America veterinary oncology market, by Therapy, 2016 - 2027 (USD Million)
TABLE 5 North America veterinary oncology market, by animal type, 2016 - 2027 (USD Million)
TABLE 6 North America veterinary oncology market, by cancer type, 2016 - 2027 (USD Million)
TABLE 7 U.S. veterinary oncology market, by Therapy, 2016 - 2027 (USD Million)
TABLE 8 U.S. veterinary oncology market, by animal type, 2016 - 2027 (USD Million)
TABLE 9 U.S. veterinary oncology market, by cancer type, 2016 - 2027 (USD Million)
TABLE 10 Canada veterinary oncology market, by Therapy, 2016 - 2027 (USD Million)
TABLE 11 Canada veterinary oncology market, by animal type, 2016 - 2027 (USD Million)
TABLE 12 Canada veterinary oncology market, by cancer type, 2016 - 2027 (USD Million)
TABLE 13 Europe veterinary oncology market, by Therapy, 2016 - 2027 (USD Million)
TABLE 14 Europe veterinary oncology market, by animal type, 2016 - 2027 (USD Million)
TABLE 15 Europe veterinary oncology market, by cancer type, 2016 - 2027 (USD Million)
TABLE 16 U.K. veterinary oncology market, by Therapy, 2016 - 2027 (USD Million)
TABLE 17 U.K. veterinary oncology market, by animal type, 2016 - 2027 (USD Million)
TABLE 18 U.K. veterinary oncology market, by cancer type, 2016 - 2027 (USD Million)
TABLE 19 Germany veterinary oncology market, by Therapy, 2016 - 2027 (USD Million)
TABLE 20 Germany veterinary oncology market, by animal type, 2016 - 2027 (USD Million)
TABLE 21 Germany veterinary oncology market, by cancer type, 2016 - 2027 (USD Million)
TABLE 22 Asia Pacific veterinary oncology market, by Therapy, 2016 - 2027 (USD Million)
TABLE 23 Asia Pacific veterinary oncology market, by animal type, 2016 - 2027 (USD Million)
TABLE 24 Asia Pacific veterinary oncology market, by cancer type, 2016 - 2027 (USD Million)
TABLE 25 Latin America veterinary oncology market, by Therapy, 2016 - 2027 (USD Million)
TABLE 26 Latin America veterinary oncology market, by animal type, 2016 - 2027 (USD Million)
TABLE 27 Latin America veterinary oncology market, by cancer type, 2016 - 2027 (USD Million)
TABLE 28 MEA veterinary oncology market, by Therapy, 2016 - 2027 (USD Million)
TABLE 29 MEA veterinary oncology market, by animal type, 2016 - 2027 (USD Million)
TABLE 30 MEA veterinary oncology market, by cancer type, 2016 - 2027 (USD Million)


List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow analysis
Fig. 10 Veterinary Oncology executive summary, 2019, (USD Million)
Fig. 11 Veterinary Oncology market revenues, 2019, (USD Million)
Fig. 12 Segment outlook
Fig. 13 Strategy framework
Fig. 14 Parent market outlook
Fig. 15 Ancillary market outlook
Fig. 16 Penetration &growth prospect mapping by technology, 2019
Fig. 17 Veterinary oncology trend analysis
Fig. 18 Veterinary oncology timeline analysis
Fig. 19 Market trends & outlook
Fig. 20 Market driver relevance analysis (Current & future impact)
Fig. 21 Market restraints relevance analysis (Current & future impact)
Fig. 22 Porter’s five force model
Fig. 23 Veterinary Oncology - SWOT analysis, by factor (political & legal, economic and technological)
Fig. 24 Market participant categorization
Fig. 25 Veterinary oncology company market position analysis
Fig. 26 Veterinary oncology market Therapy outlook: Key takeaways
Fig. 27 Veterinary oncology market: Therapy type movement analysis
Fig. 28 Global ENT market, 2016 - 2027 (USD Million)
Fig. 29 Global radiology market, 2016 - 2027 (USD Million)
Fig. 30 Global chemotherapy market, 2016 - 2027 (USD Million)
Fig. 31 Global immunotherapy market, 2016 - 2027 (USD Million)
Fig. 32 Global others market, 2016 - 2027 (USD Million)
Fig. 33 Veterinary oncology market animal type outlook: Key takeaways
Fig. 34 Veterinary oncology market: Technology type movement analysis
Fig. 35 Global canine market, 2016 - 2027 (USD Million)
Fig. 36 Global feline market, 2016 - 2027 (USD Million)
Fig. 37 Veterinary oncology market cancer type outlook: Key takeaways
Fig. 38 Veterinary oncology market: Cancer type movement analysis
Fig. 39 Global lymphoma market, 2016 - 2027 (USD Million)
Fig. 40 Global mast cell cancer market, 2016 - 2027 (USD Million)
Fig. 41 Global mammary and squamous cell cancer market, 2016 - 2027 (USD Million)
Fig. 42 Global others market, 2016 - 2027 (USD Million)
Fig. 43 Regional outlook, 2019 & 2027
Fig. 44 Regional market dashboard
Fig. 45 Regional marketplace: Key takeaways
Fig. 46 North America veterinary oncology, 2016 - 2027 (USD Million)
Fig. 47 North America veterinary oncology market by countries, 2016 - 2027 (USD Million)
Fig. 48 U.S. veterinary oncology market, 2016 - 2027 (USD Million)
Fig. 49 Canada veterinary oncology market, 2016 - 2027 (USD Million)
Fig. 50 Europe veterinary oncology, 2016 - 2027 (USD Million)
Fig. 51 Europe veterinary oncology market by countries, 2016 - 2027 (USD Million)
Fig. 52 U.K. veterinary oncology, 2016 - 2027 (USD Million)
Fig. 53 Germany veterinary oncology market, 2016 - 2027 (USD Million)
Fig. 54 Asia Pacific veterinary oncology market, 2016 - 2027 (USD Million)
Fig. 55 Latin America veterinary oncology market, 2016 - 2027 (USD Million)
Fig. 56 MEA veterinary oncology market, 2016 - 2027 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.